Evidence map›Paper›PMID 22383501›Full record

ArticleAmerican journal of respiratory and critical care medicine2012

IL-18 induces emphysema and airway and vascular remodeling via IFN-γ, IL-17A, and IL-13.

Min-Jong Kang, Je-Min Choi, Bo Hye Kim, Chang-Min Lee, Won-Kyung Cho, Gina Choe, Do-Hyun Kim, Chun Geun Lee, Jack A Elias

Abstract readComparative Study
In one paragraph

Article in American journal of respiratory and critical care medicine, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed, 1 pooled it
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 1 synthesis or guideline pooled it, 100 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Single-Cell Analysis Reveals Novel Immune Perturbations in Fibrotic Hypersensitivity Pneumonitis.American journal of respiratory and critical care medicine · 2024
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. IL-18 biology in severe asthma.Frontiers in medicine · 2024
    Review
  13. Article
  14. Review
  15. VISTA (PD-1H) Is a Crucial Immune Regulator to Limit Pulmonary Fibrosis.American journal of respiratory cell and molecular biology · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Min-Jong KangDepartment of Internal Medicine, Yale University School of Medicine, 333 Cedar Street, New Haven, CT 06520-8056, USA.
Je-Min Choi
Bo Hye Kim
Chang-Min Lee
Won-Kyung Cho
Gina Choe
Do-Hyun Kim
Chun Geun Lee
Jack A Elias
Yale University · USHanyang University · KR

Funding

Preotease/Cathepsin-Mediated Apoptosis in COPDR01HL079328 · NHLBI · YALE UNIVERSITY · PI ELIAS, JACK A · 2005 to 2012
$3.2M
Genetic Factors Controlling Effector Function of TGF-beta in COPD and FibrosisR01HL084225 · NHLBI · YALE UNIVERSITY · PI LEE, CHUN GEUN · 2007 to 2011
$2.4M
NHLBI NIH HHS HL-079328NHLBI NIH HHS HL-084225NHLBI NIH HHS R01 HL079328NHLBI NIH HHS R01 HL084225
6 · The paper itself

Abstract

rationaleChronic obstructive pulmonary disease (COPD) is characterized by chronic inflammation, alveolar destruction, and airway and vascular remodeling. However, the mechanisms that lead to these diverse alterations have not been defined.

objectivesWe hypothesized that IL-18 plays a central role in the pathogenesis of these lesions.

methodsWe generated and characterized lung-specific, inducible IL-18 transgenic mice. MEASUREMENTS AND MAIN

resultsHere we demonstrate that the expression of IL-18 in the mature murine lung induces inflammation that is associated with the accumulation of CD4(+), CD8(+), CD19(+), and NK1.1(+) cells; emphysema; mucus metaplasia; airway fibrosis; vascular remodeling; and right ventricle cardiac hypertrophy. We also demonstrate that IL-18 induces type 1, type 2, and type 17 cytokines with IFN-γ-inhibiting macrophage, lymphocyte, and eosinophil accumulation while stimulating alveolar destruction and genes associated with cell cytotoxicity and IL-13 and IL-17A inducing mucus metaplasia, airway fibrosis, and vascular remodeling. We also highlight interactions between these responses with IL-18 inducing IL-13 via an IL-17A-dependent mechanism and the type 1 and type17/type 2 responses counterregulating each another.

conclusionsThese studies define the spectrum of inflammatory, parenchymal, airway, and vascular alterations that are induced by pulmonary IL-18; highlight the similarities between these responses and the lesions in COPD; and define the selective roles that type 1, type 2, and type 17 responses play in the generation of IL-18-induced pathologies.

Indexed as

Airway ResistanceAnimalsCytokinesDisease Models, AnimalFlow CytometryImmunoblottingIn Situ Nick-End LabelingInterleukin-13Interleukin-17Interleukin-18MiceMice, Inbred C57BLMice, TransgenicPulmonary Disease, Chronic ObstructivePulmonary EmphysemaRandom AllocationCytokinesInterleukin-13Interleukin-17Interleukin-18RNA, Messenger

Identifiers

PMID22383501
PMCPMC3373071
OpenAlexW2122193920

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.